Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide for Recurrent Malignant Glioma
NCT00004113Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Jun 1999
- Primary completion
- Oct 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temozolomide in malignant glioma, sponsored by Memorial Sloan Kettering Cancer Center. Started Jun 1999; status: completed.
02
Drugs
temozolomide
03
Conditions
malignant glioma
Beyond the preview
Go deeper on NCT00004113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004113.